Retatrutide Dosage Calculator: Reconstitution and Units

To calculate retatrutide dosage, divide your target dose (mg) by the vial concentration. Concentration = vial mg ÷ diluent mL. For a 10 mg vial with 2 mL BAC water: concentration is 5 mg/mL. A 2 mg dose equals 0.4 mL (40 U-100 units) on a standard insulin syringe.

Keep exploring this topic

Explore the Retatrutide research cluster

Use these connected calculators, guides, timelines, and comparisons to move from measurement math to broader research context.

Example Retatrutide Dosage Table

Common vial and BAC water combinations with calculated concentration, draw volume, and U-100 syringe units. For education only — verify your vial label before use.

Vial (mg)BAC water (mL)ConcentrationDose (mg)Draw (mL)U-100 units
10 mg2 mL5 mg/mL1 mg0.2 mL20 units
10 mg2 mL5 mg/mL2 mg0.4 mL40 units
10 mg2 mL5 mg/mL5 mg1 mL100 units
10 mg5 mL2 mg/mL2 mg1 mL100 units

How to Calculate Retatrutide Dosage

Three steps convert any vial and BAC water combination into the exact volume to draw on a U-100 insulin syringe.

  1. Step 1 — Calculate concentration (mg/mL)

    Divide the total peptide in the vial (mg) by the volume of BAC water you added (mL). For example: a 5 mg Retatrutide vial reconstituted with 2 mL BAC water gives 5 ÷ 2 = 2.5 mg/mL.
  2. Step 2 — Calculate draw volume (mL)

    Divide your target dose (mg) by the concentration (mg/mL). For a 0.5 mg dose at 2.5 mg/mL: 0.5 ÷ 2.5 = 0.2 mL. This is the exact volume to draw into the syringe.
  3. Step 3 — Convert to U-100 syringe units

    Multiply the draw volume (mL) by 100. For 0.2 mL: 0.2 × 100 = 20 U-100 units. Read this number on the unit markings of a standard insulin syringe.

Dosage Formula

Concentration formula

Concentration (mg/mL) = Vial mg ÷ BAC water mL

Draw volume formula

Draw volume (mL) = Dose (mg) ÷ Concentration (mg/mL)

U-100 syringe units

U-100 units = Draw volume (mL) × 100

These three formulas apply to any Retatrutide vial, regardless of size. U-100 is the standard insulin-syringe scale: 100 units = 1 mL.

Retatrutide Calculator Tool

Enter your vial strength, BAC water volume, and target dose below. The calculator outputs concentration (mg/mL), draw volume (mL), and U-100 units. Educational and research use only.

Example Retatrutide Calculations

Step-by-step worked examples using common vial sizes. Results are for illustrating the math only.

10 mg vial + 2 mL BAC water, 2 mg dose

  1. Vial: 10 mg  |  BAC water: 2 mL  |  Target dose: 2 mg
  2. Concentration: 10 ÷ 2 = 5 mg/mL
  3. Draw volume: 2 ÷ 5 = 0.4 mL
  4. U-100 units: 0.4 × 100 = 40 units

10 mg vial + 5 mL BAC water, 2 mg dose

  1. Vial: 10 mg  |  BAC water: 5 mL  |  Target dose: 2 mg
  2. Concentration: 10 ÷ 5 = 2 mg/mL
  3. Draw volume: 2 ÷ 2 = 1 mL
  4. U-100 units: 1 × 100 = 100 units

Retatrutide Reconstitution Guide

Retatrutide research vials are typically supplied as lyophilised powder. Reconstitute with bacteriostatic water:

  1. Swab both stoppers with alcohol.
  2. Draw desired BAC water volume; inject slowly along vial wall.
  3. Gently swirl until dissolved. Solution should be clear.
  4. Store refrigerated. Do not freeze.

Retatrutide (LY3437943) is an investigational triple-agonist (GLP-1, GIP, glucagon) and is not an approved therapy. All use is research only.

Frequently Asked Questions

How do I calculate retatrutide draw volume?

Divide your dose (mg) by the concentration (mg/mL). For a 10 mg vial + 2 mL BAC: 5 mg/mL. For a 2 mg dose: 2 ÷ 5 = 0.4 mL = 40 U-100 units.

What are U-100 syringe units?

U-100 is the standard scale for insulin syringes. 100 units = 1.0 mL. That means 10 units = 0.1 mL, 50 units = 0.5 mL. Multiply any draw volume in mL by 100 to get the U-100 units reading.

Do I need to recalculate if I change the amount of BAC water?

Yes. Changing BAC water volume changes the concentration (mg/mL), which changes the draw volume for the same mg dose. Always recalculate using: concentration = vial mg ÷ BAC water mL, then draw volume = dose mg ÷ concentration.

What is retatrutide?

Retatrutide (LY3437943) is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) studied for obesity and metabolic outcomes. It is not an approved therapy in most regions.

Learn More

Research review and sources

Reviewed by: PeptideUniv Research Team

Updated: March 26, 2026

This page was reviewed against retatrutide clinical-trial evidence and the compound's investigational status. The math here helps translate vial strength into mL and U-100 units; it does not endorse unapproved use.

Primary references and supporting sources

Full Calculator + Protocol Tracker

The PeptideUniv app includes the full reconstitution calculator, dosing schedules, cycle tracker, and reminders — all in one place.

Open full calculator → · Start free trial →

For educational and research purposes only. Not medical advice. Consult a licensed healthcare professional before making any medical or health-related decisions.